Panbela provides business update and reports q3 2023 financial results

Minneapolis, nov. 09, 2023 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended september 30, 2023. as previously announced, management is hosting an earnings call today at 4:30 p.m. et.
PBLA Ratings Summary
PBLA Quant Ranking